AAAAAA

   
Results: 1-17 |
Results: 17
Expression of cytokeratin 20 and CD44 protein in upper urinary tract transitional cell carcinoma - Cytologic-histologic correlation
Authors: Weaver, EJ McCue, PA Bagley, DH Kovatich, AJ Bibbo, M
Citation: Ej. Weaver et al., Expression of cytokeratin 20 and CD44 protein in upper urinary tract transitional cell carcinoma - Cytologic-histologic correlation, ANAL QUAN C, 23(5), 2001, pp. 339-344
Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia
Authors: Magro, CM Crowson, AN Kovatich, AJ Burns, F
Citation: Cm. Magro et al., Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia, J CUT PATH, 28(5), 2001, pp. 235-247
Extramammary paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor
Authors: de Leon, ED Carcangiu, ML Prieto, VG McCue, PA Burchette, JL To, G Norris, BA Kovatich, AJ Sanchez, RL Krigman, HR Gatalica, Z
Citation: Ed. De Leon et al., Extramammary paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor, AM J CLIN P, 113(4), 2000, pp. 572-575
Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast - Potential diagnostic pitfall in patients with gynecomastia
Authors: Gatalica, Z Norris, BA Kovatich, AJ
Citation: Z. Gatalica et al., Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast - Potential diagnostic pitfall in patients with gynecomastia, APPL IMMUNO, 8(2), 2000, pp. 158-161
Overexpression of p21(WAF1/C1P1) and MDM2 characterizes serous borderline ovarian tumors
Authors: Palazzo, JP Monzon, F Burke, M Hyslop, T Dunton, C Barusevicius, A Capuzzi, D Kovatich, AJ
Citation: Jp. Palazzo et al., Overexpression of p21(WAF1/C1P1) and MDM2 characterizes serous borderline ovarian tumors, HUMAN PATH, 31(6), 2000, pp. 698-704
Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers
Authors: Edmonston, TB Cuesta, KH Burkholder, S Barusevicius, A Rose, D Kovatich, AJ Boman, B Fry, R Fishel, R Palazzo, JP
Citation: Tb. Edmonston et al., Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers, HUMAN PATH, 31(12), 2000, pp. 1506-1514
Fhit expression in gastric adenocarcinoma - Correlation with disease stageand survival
Authors: Capuzzi, D Santoro, E Hauck, WW Kovatich, AJ Rosato, FE Baffa, R Huebner, K McCue, PA
Citation: D. Capuzzi et al., Fhit expression in gastric adenocarcinoma - Correlation with disease stageand survival, CANCER, 88(1), 2000, pp. 24-34
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder
Authors: Baffa, R Gomella, LG Vecchione, A Bassi, P Mimori, K Sedor, J Calviello, CM Gardiman, M Minimo, C Strup, SE McCue, PA Kovatich, AJ Pagano, F Huebner, K Croce, CM
Citation: R. Baffa et al., Loss of FHIT expression in transitional cell carcinoma of the urinary bladder, AM J PATH, 156(2), 2000, pp. 419-424
Cyclin E expression and early cervical neoplasia in ThinPrep specimens - Afeasibility study
Authors: Weaver, EJ Kovatich, AJ Bibbo, M
Citation: Ej. Weaver et al., Cyclin E expression and early cervical neoplasia in ThinPrep specimens - Afeasibility study, ACT CYTOL, 44(3), 2000, pp. 301-304
p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma
Authors: Pindzola, JA Kovatich, AJ Bibbo, M
Citation: Ja. Pindzola et al., p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma, ACT CYTOL, 44(1), 2000, pp. 31-36
MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers
Authors: Simpkins, SB Bocker, T Swisher, EM Mutch, DG Gersell, DJ Kovatich, AJ Palazzo, JP Fishel, R Goodfellow, PJ
Citation: Sb. Simpkins et al., MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers, HUM MOL GEN, 8(4), 1999, pp. 661-666
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patientswith cutaneous melanoma
Authors: Mastrangelo, MJ Maguire, HC Eisenlohr, LC Laughlin, CE Monken, CE McCue, PA Kovatich, AJ Lattime, EC
Citation: Mj. Mastrangelo et al., Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patientswith cutaneous melanoma, CANC GENE T, 6(5), 1999, pp. 409-422
Calponin and h-caldesmon in soft tissue tumors: Consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smoothmuscle differentiation
Authors: Miettinen, MM Sarlomo-Rikala, M Kovatich, AJ Lasota, J
Citation: Mm. Miettinen et al., Calponin and h-caldesmon in soft tissue tumors: Consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smoothmuscle differentiation, MOD PATHOL, 12(8), 1999, pp. 756-762
Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery - Clinicopathologic and immunohistochemical study of 26 cases
Authors: Miettinen, M Monihan, JM Sarlomo-Rikala, M Kovatich, AJ Carr, NJ Emory, TS Sobin, LH
Citation: M. Miettinen et al., Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery - Clinicopathologic and immunohistochemical study of 26 cases, AM J SURG P, 23(9), 1999, pp. 1109-1118
hMSH5: A human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis
Authors: Bocher, T Barusevicius, A Snowden, T Rasio, D Guerrette, S Robbins, D Schmidt, C Burczak, J Croce, CM Copeland, T Kovatich, AJ Fishel, R
Citation: T. Bocher et al., hMSH5: A human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis, CANCER RES, 59(4), 1999, pp. 816-822
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas
Authors: Ingvarsson, S Agnarsson, BA Sigbjornsdottir, BI Kononen, J Kallioniemi, OP Barkardottir, RB Kovatich, AJ Schwarting, R Hauck, WW Huebner, K McCue, PA
Citation: S. Ingvarsson et al., Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas, CANCER RES, 59(11), 1999, pp. 2682-2689
A comparative analysis of Ki-67, p53, and p21(WAF1CIP1) expression in tamoxifen associated endometrial carcinomas
Authors: Ramondetta, LM Palazzo, JP Dunton, CJ Kovatich, AJ Carlson, JA
Citation: Lm. Ramondetta et al., A comparative analysis of Ki-67, p53, and p21(WAF1CIP1) expression in tamoxifen associated endometrial carcinomas, ANTICANC R, 18(6B), 1998, pp. 4661-4665
Risultati: 1-17 |